MEN 11270
Based on 1 Customer Validation
MEN 11270, a cyclic decapeptide, is a B2 kinin receptor antagonist. MEN 11270 bound with high-affinity to the B2 kinin receptor constitutively expressed by WI38 human fibroblasts, inhibiting 3H-bradykinin (BK) with a pKi value of 10.3.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Pureza : 98.95%
- No. CAS: 235082-52-7
- Fòrmula: C60H90N20O11S
- Peso molecular:1299.55
-
Almacenamiento:
Sealed storage, away from moisture and light.
Powder -80°C, 2 years , -20°C, 1 year* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Actividad biológica
-
Chemical Information
-
Solvente y solubilidad
- Pureza y Documentación
- Referencias
-
Help & FAQs
-
HY-17446
IcatibantBradykinin Receptor Antagonist -
HY-15043
ELN-441958Bradykinin B1 Receptor Antagonist -
![Sar-[D-Phe8]-des-Arg9-Bradykinin](https://file.medchemexpress.com/product_pic/hy-103291.gif)
HY-103291
Sar-[D-Phe8]-des-Arg9-BradykininB1 Receptor Agonist -
HY-103290
R715Bradykinin B1 Receptor Antagonist -
HY-P0206
BradykininBradykinin Receptor Modulator -
HY-108896
Icatibant acetateBradykinin B2 Antagonist -
HY-15039
SSR240612 -
HY-17446R
Icatibant (Standard)Bradykinin Receptor Antagonist -
HY-103293
Lys-BradykininKallidin -
![Lys-[Des-Arg9]Bradykinin](https://file.medchemexpress.com/product_pic/hy-103295.gif)
HY-103295
Lys-[Des-Arg9]BradykininBradykinin B1 Receptor Agonist -
![[Phe8Ψ(CH-NH)Arg9]-Bradykinin](https://file.medchemexpress.com/product_pic/hy-103292.gif)
HY-103292
[Phe8Ψ(CH-NH)Arg9]-BradykininBradykinin receptor B2 Agonist -
HY-105155
LobradimilBradykinin B2 Receptor Agonist
Ver todos los productos específicos de isoformas Bradykinin Receptor
More
Actividad biológica
Descripciòn
Chemical Information
-
No. CAS 235082-52-7
-
Appearance Solid
-
Peso molecular 1299.55
-
Fòrmula C60H90N20O11S
-
Color White to off-white
-
Sequence
{d-Arg}-Arg-Pro-{Hyp}-Gly-{Thi}-c({Dab}-{d-Tic}-{Oic}-Arg)c(7γ-10α)
-
Sequence Shortening
{d-Arg}-RP-{Hyp}-G-{Thi}-c({Dab}-{d-Tic}-{Oic}-R)c(7γ-10α)
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Sealed storage, away from moisture and light
Powder -80°C 2 years -20°C 1 year * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
Solvente y solubilidad
In Vitro:
DMSO : 100 mg/mL (76.95 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
In Vivo:
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (1.92 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.5 mg/mL (1.92 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL. * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Pureza y Documentación
-
Ficha de datos (280 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Instrucciones de manejo (2659 KB)
Referencias
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 0.7695 mL | 3.8475 mL | 7.6950 mL | 19.2374 mL |
| 5 mM | 0.1539 mL | 0.7695 mL | 1.5390 mL | 3.8475 mL | |
| 10 mM | 0.0769 mL | 0.3847 mL | 0.7695 mL | 1.9237 mL | |
| 15 mM | 0.0513 mL | 0.2565 mL | 0.5130 mL | 1.2825 mL | |
| 20 mM | 0.0385 mL | 0.1924 mL | 0.3847 mL | 0.9619 mL | |
| 25 mM | 0.0308 mL | 0.1539 mL | 0.3078 mL | 0.7695 mL | |
| 30 mM | 0.0256 mL | 0.1282 mL | 0.2565 mL | 0.6412 mL | |
| 40 mM | 0.0192 mL | 0.0962 mL | 0.1924 mL | 0.4809 mL | |
| 50 mM | 0.0154 mL | 0.0769 mL | 0.1539 mL | 0.3847 mL | |
| 60 mM | 0.0128 mL | 0.0641 mL | 0.1282 mL | 0.3206 mL |
MEN 11270 Related Classifications
HY-103289 Related Classifications
Powered by Bioz